Seaport Therapeutics has filed to go public. The buzzy Boston biotech was founded by the same team behind the local success story Karuna Therapeutics, which was bought by Bristol Myers Squibb for $14 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. A wave of business succession and other factors increases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results